Loading data for PPCB — first visit, this takes a few seconds.
Propanc Biopharma Inc. (PPCB)
NasdaqCM: PPCB
· リアルタイム株価 · USD
1.16
+0.01 (0.87%)
終値時点: Aug 18, 2026, 8:00 PM
1.20
+3.14%
寄り付き前: 6:21 AM
Propanc Biopharma Inc. (PPCB) Stock Price, Analysis & Data
0.87% (1D)
データがありません
PPCBについて
Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreemen...
企業情報の全文
